TRANSDERMAL IONTOPHORESIS AND POLYPEPTIDE DELIVERY
透皮离子电渗疗法和多肽输送
基本信息
- 批准号:2608906
- 负责人:
- 金额:$ 19.46万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1989
- 资助国家:美国
- 起止时间:1989-12-01 至 1999-11-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
This proposal seeks to implement a novel, systematic approach (developed
during the past project period) to study the iontophoretic transport
properties of human skin. The long term objective is to gain a basic and
comprehensive understanding with the information to become a significant
part of the fundamental data base to materially assist drug delivery
scientists in the rational design of practical iontophoretic systems for
trans- dermal drug delivery, especially for polypeptide drug delivery. The
approach combines a rigorous theoretical framework (the modified Nernst-
Planck theory) with judiciously designed experiments to factor out the
various contributions to human skin iontophoresis. The effects of physical
chemical factors such as the molecular size/configuration and charge of
the permeant, the ionic strength and pH of the electrolyte solution, and
the mode of iontophoresis (continuous D.C. versus pulsed D.C.) upon the
iontophoretic flux of the permeant will be systematically investigated.
The general question will be addressed: is polypeptide transport (both
passive and iontophoretic) in accord with the modified Nernst-Planck
theory? The phenomenon of field induced pore induction (electroporation)
with the human epidermal membrane (HEM) will receive particular attention,
and answers to the following questions will be sought. How do HEM
permeability and pore size vary with amplitude and duration of the applied
voltage? How do the relative contributions of the direct field effect and
convective (electroosmotic) solvent flow vary with electroporation? Under
what voltage regimens may alternating pulses or sinusoidal A.C. yield
electroporation effects? The actions of chemical permeation enhancers
operating via several different mechanisms will be systematically
investigated, and the importance of the different mechanisms quantified.
These enhancer situations will include (a) agents interacting directly
with HEM to increase the effective pore size and/or the porosity/
tortuosity ratio, (b) enhancers influencing the rate, extent, and/or the
threshold voltage of electroporation, and (c) agents influencing the
direction and magnitude of electroosmosis. Finally, select studies will be
conducted to assess the clinical relevance of important outcomes from the
above in vitro HEM studies in an in vivo animal model (developed during
the past project period).
该提案旨在实施一种新的、系统的方法(制定),
在过去的项目期间),以研究离子电渗运输
人体皮肤的特性。 长期目标是获得一个基本的,
全面了解与信息,成为一个重要的
基本数据库的一部分,以实质性地帮助药物输送
科学家在合理设计的实用离子电渗系统,
透皮药物递送,特别是用于多肽药物递送。的
方法结合了严格的理论框架(修改后的能斯特,
普朗克理论)与明智设计的实验,以因素出
对人体皮肤离子电渗疗法的各种贡献。物理的影响
化学因素,如分子大小/构型和电荷
渗透物、电解质溶液的离子强度和pH,以及
离子电渗疗法的模式(连续D.C.与脉冲D.C.)于
将系统地研究渗透物的离子电渗通量。
一般的问题将得到解决:是多肽运输(两者)
被动和离子电渗)符合雅阁修正的能斯特-普朗克
理论?场致孔诱导(电穿孔)现象
与人表皮膜(HEM)的关系将受到特别关注,
并将寻求以下问题的答案。HEM如何
渗透率和孔径随施加的振幅和持续时间而变化
电压?直接场效应的相对贡献和
对流(电渗)溶剂流动与电穿孔的变化?下
交流脉冲或正弦交流电的电压方案产量
电穿孔效应?化学促渗剂的作用
通过几种不同的机制运作,
调查,并量化不同机制的重要性。
这些增强子的情况将包括(a)直接相互作用的药剂
用HEM增加有效孔径和/或孔隙率,
(B)影响弯曲速率、程度和/或弯曲程度的增强剂,
电穿孔的阈值电压,和(c)影响电穿孔的试剂。
电渗的方向和大小。最后,选择研究将
进行评估的重要结果的临床相关性,
以上在体内动物模型中的体外HEM研究(在本发明期间开发的),
项目前期)。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
A liposome permeability model for stratum corneum lipid bilayers based on commercial lipids.
基于商业脂质的角质层脂质双层的脂质体渗透性模型。
- DOI:10.1002/jps.21306
- 发表时间:2008
- 期刊:
- 影响因子:3.8
- 作者:Suhonen,Marjukka;Li,SKevin;Higuchi,WilliamI;Herron,JamesN
- 通讯作者:Herron,JamesN
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
William I Higuchi其他文献
William I Higuchi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('William I Higuchi', 18)}}的其他基金
Novel Method for the Ocular Iontophoretic Delivery of Avastin and Lucentis
眼部电离子导入阿瓦斯汀和雷珠单抗的新方法
- 批准号:
7927575 - 财政年份:2010
- 资助金额:
$ 19.46万 - 项目类别:
TRANSDERMAL IONTOPHORESIS AND POLYPEPTIDE DELIVERY
透皮离子电渗疗法和多肽输送
- 批准号:
2022341 - 财政年份:1989
- 资助金额:
$ 19.46万 - 项目类别:
TRANSDERMAL IONTOPHORESIS AND POLYPEPTIDE DELIVERY
透皮离子电渗疗法和多肽输送
- 批准号:
2181850 - 财政年份:1989
- 资助金额:
$ 19.46万 - 项目类别:
TRANSDERMAL IONTOPHORESIS AND POLYPEPTIDE DELIVERY
透皮离子电渗疗法和多肽输送
- 批准号:
2181851 - 财政年份:1989
- 资助金额:
$ 19.46万 - 项目类别:
相似海外基金
ERI: Revealing the Reconfiguration Dynamics of Lipid Bilayer and Its Hydration Structures with Nanoscale Resolution during Electroporation
ERI:以纳米级分辨率揭示电穿孔过程中脂质双层的重构动力学及其水合结构
- 批准号:
2302013 - 财政年份:2023
- 资助金额:
$ 19.46万 - 项目类别:
Standard Grant
Optimization of High Frequency Irreversible Electroporation (H-FIRE) for tumor ablation and immune system activation in pancreatic cancer applications
高频不可逆电穿孔 (H-FIRE) 的优化,用于胰腺癌应用中的肿瘤消融和免疫系统激活
- 批准号:
10659581 - 财政年份:2023
- 资助金额:
$ 19.46万 - 项目类别:
Irreversible Electroporation (IRE) Combined with CD40 Agonism as In Situ Vaccine Therapy for Pancreatic Cancer
不可逆电穿孔 (IRE) 联合 CD40 激动作为胰腺癌原位疫苗治疗
- 批准号:
10718057 - 财政年份:2023
- 资助金额:
$ 19.46万 - 项目类别:
Self-powered disinfection of Viruses and Bacteria in water using Oxidation-assisted electroporation and Tribo-Electric Nanogenerators (VIBO-TENG)
使用氧化辅助电穿孔和摩擦纳米发电机 (VIBO-TENG) 对水中的病毒和细菌进行自供电消毒
- 批准号:
EP/X022730/1 - 财政年份:2023
- 资助金额:
$ 19.46万 - 项目类别:
Fellowship
Identification of impedance measurement devices, heating hardware, and operating parameters to augment instrumentation for a commercial in vivo electroporation system
识别阻抗测量装置、加热硬件和操作参数,以增强商业体内电穿孔系统的仪器
- 批准号:
10484502 - 财政年份:2022
- 资助金额:
$ 19.46万 - 项目类别:
Development of irreversible electroporation-based rational combinations to potentiate the activity of cancer immunotherapy against pancreatic ductal adenocarcinoma
开发基于不可逆电穿孔的合理组合以增强癌症免疫疗法对胰腺导管腺癌的活性
- 批准号:
10363932 - 财政年份:2022
- 资助金额:
$ 19.46万 - 项目类别:
Adaptable and scalable electroporation for cellular therapy
用于细胞治疗的适应性和可扩展的电穿孔
- 批准号:
10545845 - 财政年份:2022
- 资助金额:
$ 19.46万 - 项目类别:
Development of irreversible electroporation-based rational combinations to potentiate the activity of cancer immunotherapy against pancreatic ductal adenocarcinoma
开发基于不可逆电穿孔的合理组合以增强癌症免疫疗法对胰腺导管腺癌的活性
- 批准号:
10559607 - 财政年份:2022
- 资助金额:
$ 19.46万 - 项目类别:
ex vivo electroporation培養法による歯の運命決定因子の探索
利用离体电穿孔培养法寻找决定牙齿命运的因素
- 批准号:
22K17233 - 财政年份:2022
- 资助金额:
$ 19.46万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Academic-Industrial Partnership to Develop Clinical Tools for Algorithmic Irreversible Electroporation of Inoperable Tumors
学术与工业合作开发用于不可手术肿瘤的算法不可逆电穿孔的临床工具
- 批准号:
10504276 - 财政年份:2022
- 资助金额:
$ 19.46万 - 项目类别:














{{item.name}}会员




